Development of TRAIL Resistance by Radiation-Induced Hypermethylation of DR4 CpG Island in Recurrent Laryngeal Squamous Cell Carcinoma
- 1 April 2014
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 88 (5) , 1203-1211
Abstract
No abstract availableKeywords
Funding Information
- Bio & Medical Technology Department Program of the National Research Foundation (2012028788)
- Asan Institute for Life Sciences (2012-073)
- Biomedical Research Center Promotion Fund (UUH-2012-06)
- MEST (2009-0094050)
This publication has 32 references indexed in Scilit:
- Radiotherapy and TRAIL for cancer therapyCancer Letters, 2013
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistanceDrug Resistance Updates, 2012
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination TherapiesMolecular Cancer Therapeutics, 2012
- Identification of Hypermethylated Genes Associated with Cisplatin Resistance in Human CancersCancer Research, 2010
- The TRAIL apoptotic pathway in cancer onset, progression and therapyNature Reviews Cancer, 2008
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Head and neck cancerThe Lancet, 2008
- Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targetsMolecular Cancer Therapeutics, 2007
- Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy, or Chemotherapy Alone?Journal of Clinical Oncology, 2006
- Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapyProceedings of the National Academy of Sciences, 2000